SCHEMBL6950459

SCHEMBL6950459

CN(CCO)S(=O)(=O)c1ccc2c(c1)C(Cl)(Cl)C(=O)N2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
CASP3 P42574 4/20 0.47
PKLR P30613 1/20 0.46
GAA P10253 2/20 0.43
MAOA P21397 3/20 0.40
MAOB P27338 2/20 0.40
IKBKB O14920 1/20 0.40
CHUK O15111 1/20 0.40
AURKB Q96GD4 1/20 0.40
AURKAIP1 Q9NWT8 1/20 0.40
NEK1 Q96PY6 1/20 0.39
NAMPT P43490 1/20 0.38
SLC6A4 P31645 1/20 0.38
RAF1 P04049 1/20 0.38
VCAM1 P19320 2/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307133 0.85 CASP3 (0.63) ALDH1A1CASP3PKLRGAAMAOA
SCHEMBL6946269 0.84 PKLR (0.44) KMT2AALDH1A1KDM4ECASP3PKLR
SCHEMBL6949029 0.81 PKLR (0.42) ALDH1A1CASP3PKLRGAAMAOA
SCHEMBL8307006 0.80 PKLR (0.42) ALDH1A1KDM4ECASP3PKLRGAA
SCHEMBL8307129 0.79 PKLR (0.50) ALDH1A1RXFP1KDM4EPKLRGAA
SCHEMBL7566978 0.77 CASP3 (0.74) KMT2AALDH1A1RXFP1KDM4EMEN1
SCHEMBL6954051 0.73 PKLR (0.55) KMT2AALDH1A1KDM4EMEN1PKLR
SCHEMBL26376297 0.70 KMT2A (0.58) KMT2AALDH1A1RXFP1KDM4EMEN1
SCHEMBL11576737 0.70 CA12 (0.59) KMT2AALDH1A1RXFP1KDM4EMEN1
SCHEMBL2414975 0.70 SIGMAR1 (0.57) KMT2AALDH1A1RXFP1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP claimed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US claimed
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP disclosed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US disclosed